Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 132 publications
Factors Impacting Overall Survival Post-Relapse in High-Risk Neuroblastoma: Children's Oncology Group Outcomes From 2000 to 2019.
Journal: Pediatric blood & cancer
Published: March 16, 2026
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project.
Journal: JCO global oncology
Published: December 23, 2025
Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I-Metaiodobenzylguanidine Radiotherapy in the Anti-GD2 Immunotherapy Era.
Journal: Pediatric blood & cancer
Published: December 22, 2025
The Price of Survival: Global Inequities in Anti-GD2 Immunotherapy for Neuroblastoma.
Journal: Pediatric blood & cancer
Published: August 31, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 23, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancers.
Journal: Journal of the National Cancer Institute
Published: June 22, 2025
International neuroblastoma risk group consortium: a model of networking for rare cancers.
Journal: Journal of the National Cancer Institute
Published: June 22, 2025
Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma.
Journal: Cancer research
Published: August 12, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Journal: Pediatric blood & cancer
Published: January 30, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Journal: British journal of cancer
Published: October 10, 2023
Last Updated: 09/26/2026